Comparison of intensive, pediatric-inspired therapy with non-intensive therapy in older adults aged 55-65 years with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Sign Up to like & getrecommendations! Published in 2018 at "Leukemia research"
DOI: 10.1016/j.leukres.2018.03.010
Abstract: BACKGROUND AND OBJECTIVE The standardization of treatment of older adults with Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL) is challenging, especially in the age range of 55-65 years. This study aimed to compare intensive,… read more here.
Keywords: pediatric inspired; chromosome negative; negative acute; philadelphia chromosome ... See more keywords
The outcome of Ph-negative acute lymphoblastic leukemia presenting during pregnancy and treated on the Russian prospective multicenter trial RALL-2009.
Sign Up to like & getrecommendations! Published in 2021 at "Leukemia research"
DOI: 10.1016/j.leukres.2021.106536
Abstract: We report the data on 15 women who presented with Ph-negative acute lymphoblastic leukemia (ALL) between Jan 2009 until Dec 2016 and who were treated on the prospective multicenter RALL-2009 clinical trial. A comparison of… read more here.
Keywords: outcome; lymphoblastic leukemia; negative acute; acute lymphoblastic ... See more keywords
Successful Treatment of Adolescents and Young Adults with Philadelphia-Negative Acute Lymphoblastic Leukemia by Novel L-Asparaginase-Intensified Induction Therapy and Cord Blood Transplantation: A Single-Center Decade Report.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of adolescent and young adult oncology"
DOI: 10.1089/jayao.2017.0120
Abstract: A novel induction therapy, including intensive L-asparaginase, was designed in 2007 for patients aged read more here.
Keywords: philadelphia negative; induction therapy; negative acute; acute lymphoblastic ... See more keywords
Prospective evaluation of minimal residual disease monitoring to predict prognosis of adult patients with Ph‐negative acute lymphoblastic leukemia
Sign Up to like & getrecommendations! Published in 2019 at "European Journal of Haematology"
DOI: 10.1111/ejh.13268
Abstract: We investigated whether minimal residual disease (MRD) status in adult patients with Philadelphia chromosome (Ph)‐negative acute lymphoblastic leukemia (ALL) is useful for decision on clinical indications for allogeneic hematopoietic stem cell transplantation (HSCT). read more here.
Keywords: minimal residual; lymphoblastic leukemia; residual disease; negative acute ... See more keywords